Natural host resistance to infection with Cryptococcus neoformans. IV. The effect of some cationic proteins on the experimental disease.
D000818:Animals; D003453:Cryptococcosis / Q000276:immunology*; D003454:Cryptococcus / Q000472:pathogenicity*; D003470:Culture Media; D003851:Deoxyribonucleases / Q000494:pharmacology; D004285:Dogs; D006168:Guinea Pigs; D006657:Histones / Q000494:pharmacology; D066298:In Vitro Techniques; D007668:Kidney; D008099:Liver; D051379:Mice; D009113:Muramidase / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology*; D011506:Proteins / Q000494:pharmacology*; D012313:RNA / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D013154:Spleen; D014020:Tissue Extracts / Q000494:pharmacology
D003470:Culture Media; D006657:Histones; D010455:Peptides; D011506:Proteins; D014020:Tissue Extracts; D012313:RNA; D003851:Deoxyribonucleases; D009113:Muramidase